News ArchivesRead News
Transcript: Former Chairman & CEO, NEXT
Wednesday November 22, 2006
November 20, 2006 (CNN) - British fashion retailer NEXT is a well known High Street name. Former chairman and chief executive David Jones has been widely credited with making it that way.
In the 1980s, he took a battered and almost bankrupt chain and turned it into a success story. All the while fighting Parkinson’s disease -- in secret.
CNN’s Todd Benjamin caught up with him at a London hotel and started by asking him about his early working life.
Benjamin: You worked from an early age. Even as a young man you had a paper route.
Jones: Well that was circumstances. I just found out quite by chance, that my parents weren’t as rich as I thought they were, and my father was maybe dangling from his job. And I suddenly realized, that when my mother couldn’t afford a school uniform for me, I should do something to help the family cause. So I got a paper run when I was aged about twelve-and-a-half to 13. Used to get up at five o’clock in the morning and deliver papers and that taught me something about people. When Christmas came I got 90 percent of my tips from the flats, and the slightly poorer people, but nothing from the rich people.
Benjamin: Do you think, you were a different leader when you were in your thirties versus now that you’re in your sixties?
Jones: I think that I was exactly the same type of leader in my thirties as I am in my sixties. I was considerate towards people. I tried to make people find the answer to problems themselves and not be told what the answer was. I think that, you have to recognize in my view, that everybody is an expert at something. Even the toilet cleaner, or the lift attendant knows their job better than you do.
Benjamin: I want to ask you about your Parkinson’s disease, because life had been quite good to you up until that point. You were a rising executive, and then all of a sudden, at 39, you go to your doctor and your doctor tells you, you have Parkinson’s disease. That must have been a devastating moment for you?
Jones: It’s probably the most devastating thing that has ever happened to me. I remember walking out of the consultant surgery, walking around the car park, and saying: "What on earth am I going to do?" I decided the best thing to do, was not to tell anybody. I didn’t tell my wife for three years and because the deception had to be complete, in my own mind, I created two people. The David Jones who was a chief executive and the David Jones who had P.D. I decided to keep them apart for about 20 years.
Benjamin: What was the most challenging part of dealing with Parkinson’s disease? Because that must have been extremely difficult, having these two separate roles. You said you didn’t tell your wife for three years, I know, you didn’t tell anyone else for 20 years.
Jones: Up until the late 1990s it was not difficult, medication kept it under control. After about 1999 it became more difficult as the condition deteriorated and by the time I got to 2002, I really had to tell people, because it was getting far more difficult to hide and the pain of hiding it was actually worse than the pain of the disease itself.
Benjamin: But even up until that moment when you let your friends and colleagues know, that you had Parkinson’s disease, you basically would try and regulate the Parkinson’s disease in terms of when you had meetings and so forth, through your medication?
Jones: In order to be fit to talk to you now, I was up at 6 o’clock this morning, took my medication and at this point in time I’m okay. In an hour and a half’s time I’ll probably be shaking quite violently.
Benjamin: Do you think, that you should be considered exceptional because of what you accomplished because you had Parkinson’s?
Jones: Not at all. No, I think the Parkinson’s; the other fellow had it. Not me. Parkinson’s had nothing to do with my success.
Recent NewsSep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement